I have only become a shareholder.
Having experienced a dramatic drop in my my cholesterol over a 6 month period after taking a medlab product (BioClean EPAHA + Plant Sterols), I decided to take a small position. I will most certainly add to it if the stock price starts heading higher.
But why is the share price under so much pressure?
One problem seems to be that the company does not have enough sales to pay for its research activities. Obviously, a big win in a cannabis trial could change all that.
What are the other catalysts for a turnaround?
I have only become a shareholder. Having experienced a dramatic...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.60 |
Change
0.000(0.00%) |
Mkt cap ! $15.07M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| MDC (ASX) Chart |
Day chart unavailable